Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	2468-2469
Number of pages	2
Journal	JACC: Cardiovascular Interventions
Volume	10
Issue number	23
DOIs	https://doi.org/10.1016/j.jcin.2017.10.003
State	Published - 11 Dec 2017

Access to Document

@article{a885ead319f14c8e9d66bf8722d67063,

title = "Reply: Cangrelor or Abciximab as First Choice in Cardiogenic Shock",

author = "Muthiah Vaduganathan and Arman Qamar and Badreldin, \{Hisham A.\} and Faxon, \{David P.\} and Bhatt, \{Deepak L.\}",

year = "2017",

month = dec,

day = "11",

doi = "10.1016/j.jcin.2017.10.003",

language = "English",

volume = "10",

pages = "2468--2469",

journal = "JACC: Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Inc.",

number = "23",

}

TY - JOUR

T1 - Reply

T2 - Cangrelor or Abciximab as First Choice in Cardiogenic Shock

AU - Vaduganathan, Muthiah

AU - Qamar, Arman

AU - Badreldin, Hisham A.

AU - Faxon, David P.

AU - Bhatt, Deepak L.

PY - 2017/12/11

Y1 - 2017/12/11

UR - https://www.scopus.com/pages/publications/85038078627

U2 - 10.1016/j.jcin.2017.10.003

DO - 10.1016/j.jcin.2017.10.003

M3 - Letter

C2 - 29217013

AN - SCOPUS:85038078627

SN - 1936-8798

VL - 10

SP - 2468

EP - 2469

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 23

ER -